NIH-funded research R01 grant

Exploring how gut bacteria metabolites influence immune responses

Official title: Chemoproteomic discovery and functional analysis microbiota bile acid-protein targets in host immunity

Funded at Scripps Research Institute, the · NIH-11068923 · Data updated 2026-11-12

This study is looking at how substances made by gut bacteria can influence our immune system, and it's for anyone interested in finding new ways to treat infections and cancer in both people and animals.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionScripps Research Institute, the
NIH-funded
Lab location1 site (La Jolla, United States)
Project startDecember 9, 2024
Project endNovember 30, 2029
Funding year2025
Award (this year)$891,678
NIH project number1R01AI182439-01A1
Project IDNIH-11068923 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with immune-related conditions or those at risk for infections and cancer.

Less likely to help

Patients who do not have immune-related conditions or are not affected by gut microbiota may not benefit from this research.

What this research studies

This research investigates how key metabolites produced by gut bacteria, such as bile acids, affect the immune system. By using advanced techniques in chemical biology and proteomics, the study aims to identify the specific proteins these metabolites interact with in mammalian cells. The research will involve both laboratory experiments and mouse models to understand the mechanisms of action of these metabolites on host immunity. The ultimate goal is to uncover new therapeutic targets that could lead to improved treatments for infections and cancer in both animals and humans.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that enhance immune responses against infections and cancer.

How similar studies have gone: Previous research has shown promise in understanding the role of gut microbiota in immune modulation, suggesting potential for success in this area.

Where this research is happening

  • Scripps Research Institute, the
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Hang, Howard C — Scripps Research Institute, the
  • Study coordinator: Hang, Howard C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.